Article Details
Retrieved on: 2021-06-23 13:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The Third Rock Ventures-backed startup has a pipeline of regulatory T cell (Treg) therapeutics aimed at multiple sclerosis, type 1 diabetes and ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here